Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $766000.0.

  • Cross Country Healthcare's Share-based Compensation fell 1195.4% to $766000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 1531.04%. This contributed to the annual value of $6.0 million for FY2024, which is 842.07% down from last year.
  • Cross Country Healthcare's Share-based Compensation amounted to $766000.0 in Q3 2025, which was down 1195.4% from $870000.0 recorded in Q2 2025.
  • Cross Country Healthcare's Share-based Compensation's 5-year high stood at $2.3 million during Q2 2024, with a 5-year trough of $766000.0 in Q3 2025.
  • Moreover, its 5-year median value for Share-based Compensation was $1.6 million (2022), whereas its average is $1.6 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 6644.74% in 2021, then tumbled by 6148.74% in 2025.
  • Cross Country Healthcare's Share-based Compensation (Quarter) stood at $1.6 million in 2021, then soared by 33.6% to $2.2 million in 2022, then tumbled by 46.68% to $1.2 million in 2023, then surged by 45.63% to $1.7 million in 2024, then tumbled by 54.89% to $766000.0 in 2025.
  • Its Share-based Compensation was $766000.0 in Q3 2025, compared to $870000.0 in Q2 2025 and $1.3 million in Q1 2025.